loader image
Monday, October 6, 2025
95.6 F
McAllen
- Advertisement -

Drug Shows Promising Results for Serious Heart Condition

Translate to Spanish or other 102 languages!

A Medication used in a clinical trial is showing some promising results for people with hypertrophic cardiomyopathy, or HCM for short. Image for illustration purposes
A Medication used in a clinical trial is showing some promising results for people with hypertrophic cardiomyopathy, or HCM for short. Image for illustration purposes

Mega Doctor News

- Advertisement -

CLEVELAND CLINIC –A Medication used in a clinical trial is showing some promising results for people with hypertrophic cardiomyopathy, or HCM for short.

The disease, which causes abnormal thickening of the heart muscle, affects between 15 and 20 million people worldwide.

“Common symptoms are shortness of breath, dizziness with exertion and lightheadedness. Occasionally, they may have chest pain and passing out, commonly with exertion or due to arrhythmias,” explained Milind Desai, MD, cardiologist for Cleveland Clinic and principal investigator for the clinical trial.

- Advertisement -

Dr. Desai said they wanted to explore newer medical therapies for patients with HCM, so they decided to test the medication “Mavacamten.”

Based on the results, it appears to be an effective form of treatment for those who would have otherwise needed an invasive procedure.

Dr. Desai said patients who took the medication reported an improvement in symptoms and quality of life.

“This disease has been barely recognized for about 60 odd years, so the evolution of diagnostic techniques in this disease, the evolution of invasive techniques in this disease and now the evolution of precision medications in this disease is huge if you take the spectrum of time we are talking about,” said Dr. Desai.

- Advertisement -

The medication used in the trial is currently awaiting approval from the FDA.

- Advertisement -
- Advertisement -

- Advertisement -

More Articles

Unidos Contra la Diabetes to Host 2026 Mini-Symposium and Annual Dia-Beat-IT Health Fair, Nov. 5th

Unidos Contra la Diabetes (UCD) has announced that its 2026 Mini-Symposium and Annual Dia-Beat-IT Health Fair is less than a month away. Moises Arjona Jr., MS, CHWI, Collective Impact Director for UCD, reminded community partners and stakeholders of the upcoming event, encouraging participation and support.

STHS Hosting Muscle Strengthening Session for Seniors for Fall Prevention, Oct. 8th

Mega Doctor News Muscle loss, a condition referred to as sarcopenia, is a...

More Women Under 50 Are Getting Breast Cancer

Mega Doctor News By American College of Surgeons (ACS) Newswise — CHICAGO — About 1...

Ignoring cholesterol until middle age is a bad idea

Unhealthy cholesterol levels are a major risk factor for heart disease and stroke. Bowers, now a nursing professor at Purdue University Northwest in Hammond, Indiana, has attempted to address the issue. But she agreed cholesterol management is not something young adults usually worry about.
- Advertisement -
×